Penumbra, Inc. (PEN)
341.02
-0.99
(-0.29%)
USD |
NYSE |
Feb 06, 16:00
340.88
-0.14
(-0.04%)
After-Hours: 20:00
Penumbra SG&A Expense (TTM) : 630.26M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Boston Scientific Corp. | 6.888B |
| Zimmer Biomet Holdings, Inc. | 3.132B |
| Globus Medical, Inc. | 1.113B |
| iRhythm Holdings, Inc. | 470.32M |
| Rapt Therapeutics, Inc. | 29.76M |